This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
protein
product name :
Vimentin (human), (recombinant)
catalog :
ADI-908-280-010
quantity :
10 µg
product information
Product ID :
ADI-908-280
Catalog Number :
ADI-908-280-010
Product Name :
Vimentin (human), (recombinant)
Product Type :
Protein
Size :
10 µg
Background :
Vimentin is an ~58 kDa intermediate filament protein distributed widely in the cytoplasm and is phosphorylated by several protein kinases in vitro. Components of intermediate filaments provide information on the origin of vertebrate cells. Antibody to vimentin can be used as to identify the vimentin subclass of intermediate filaments. Vimentin is a widely expressed protein that is thought to be involved mainly in structural processes, such as wound healing. Researchers have also determined that activated human macrophages secrete vimentin into the extracellular space, and overproduction of vimentin has been associated with cellular senescence.
ALTnames :
VIM
Buffer :
Liquid. In 50mM Tris-HCl, pH 7.5, containing 10mM L-glutathione (reduced).
Uses :
Western blot control.
Application Summary :
ELISA, WB, Inhibition assay
Storage :
-80°C
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.
questions and comments